Page last updated: 2024-10-29

avapro and Blood Clot

avapro has been researched along with Blood Clot in 2 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"Pathogenic thrombus formation accounts for the etiology of many serious conditions including myocardial infarction, stroke, deep vein thrombosis, and pulmonary embolism."1.56Progress toward a Glycoprotein VI Modulator for the Treatment of Thrombosis. ( Foster, H; Foster, R; Philippou, H; Wilson, C, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Foster, H1
Wilson, C1
Philippou, H1
Foster, R1
Hayashi, M1
Takeshita, K1
Uchida, Y1
Yamamoto, K1
Matsushita, T1
Murohara, T1

Other Studies

2 other studies available for avapro and Blood Clot

ArticleYear
Progress toward a Glycoprotein VI Modulator for the Treatment of Thrombosis.
    Journal of medicinal chemistry, 2020, 11-12, Volume: 63, Issue:21

    Topics: Binding Sites; Biological Products; Humans; Ligands; Losartan; Molecular Dynamics Simulation; Platel

2020
Angiotensin receptor blocker improves a stress-induced prothrombotic state in a murine model.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2016, Volume: 27, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Humans; Hypertension; Irbesart

2016